The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRecord Regulatory News (REC)

Share Price Information for Record (REC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 62.00
Bid: 60.40
Ask: 62.00
Change: 0.60 (0.98%)
Spread: 1.60 (2.649%)
Open: 63.80
High: 65.60
Low: 60.40
Prev. Close: 61.40
REC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Second Quarter Trading Update

20 Oct 2023 07:00

RNS Number : 7361Q
Record PLC
20 October 2023
 

20 October 2023

RECORD PLC

SECOND QUARTER TRADING UPDATE

 

Record plc ("Record" or the "Company"), the specialist currency and asset manager, is pleased to announce its trading update for the three months ended 30 September 2023 ("Q2-2024").

 

Q2-2024 Highlights

 

· Performance fees of £1.0 million earned during the quarter (FY-24 YTD: £1.5 million)

· AUME of US$84.5 billion, including net inflows of US$1.5 billion for the quarter

 

Leslie Hill, Chief Executive of Record plc, commented:

 

"It is pleasing to report further performance fees of £1.0 million and net inflows of US$1.5 billion for the quarter.

 

"In our currency hedging business, our focus continues to be on providing the highest levels of service and proactivity to our clients to reinforce both the longstanding relationships built over many years and the trust they continue to place in Record as their solutions-led currency hedging manager.

 

"Our plans for diversification through our asset management and digital asset businesses continue to progress well, albeit in places more gradually than initially envisaged, and I look forward to giving more detail on our strategic progress at our forthcoming half-year results in November."

 

Trading Analysis

 

1. AUME composition

The Group's AUME as at 30 September 2023 totalled US$84.5 billion (30 June 2023: US$86.4 billion), and expressed in sterling totalled £69.2 billion (30 June 2023: £68.0 billion). The composition of AUME by product was as follows:

 

AUME - US$ billion

30 September 2023

30 June 2023

Dynamic Hedging

14.5

15.3

Passive Hedging

60.5

61.6

Currency for Return

3.9

4.1

Multi-Product

5.3

5.3

Cash & Futures/other

0.3

0.1

Total

84.5

86.4

 

2. AUME Movement

Net client AUME movement in the three months to 30 September 2023 was as follows:

 

Net AUME movement - US$ billion

3 months to

30 September 2023

3 months to

30 June 2023

Dynamic Hedging

0.0

0.3

Passive Hedging

1.7

(3.0)

Currency for Return

(0.3)

0.1

Multi-Product

(0.1)

0.1

Cash & Futures/other

0.2

0.0

Total net flows

1.5

(2.5)

FX movements and mandate volatility targeting

(1.5)

1.2

Movements in global stock and other markets

(1.9)

0.0

TOTAL AUME MOVEMENT

(1.9)

(1.3)

 

3. AVERAGE FEE RATES AND PERFORMANCE FEES

 

During Q2-2024, average fee rates remained broadly unchanged from the previous quarter.

 

Performance fees of £1.0 million were earned in the quarter.

 

Record will announce its half year results on 17 November 2023 and its third quarter trading update on 26 January 2024.

 

-Ends -

 

 

For further information, please contact:

 

Record plc

Leslie Hill, Chief Executive Officer

Steve Cullen, Chief Finance Officer

 

Tel: +44 (0) 1753 852 222

Buchanan

Simon Compton

Henry Wilson

George Beale

Tel: +44 (0) 20 7466 5000

record@buchanan.uk.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTEANENFEXDFFA
Date   Source Headline
26th Apr 20247:00 amRNSFourth Quarter Trading Update
25th Apr 20247:00 amRNSSenior Subsidiary Appointments
5th Apr 20243:48 pmRNSDirector/PDMR Shareholding
28th Mar 202412:12 pmRNSDirector/PDMR Shareholding
27th Mar 202410:30 amRNSDirector/PDMR Shareholding
22nd Mar 20247:00 amRNSTrading and Business Update
16th Feb 20243:36 pmRNSHolding(s) in Company
26th Jan 20247:00 amRNSThird Quarter Trading Update
15th Jan 20247:00 amRNSDirectorate Change
3rd Jan 20242:22 pmRNSDirector/PDMR Shareholding
22nd Dec 20239:20 amRNSDirector/PDMR Shareholding
13th Dec 20239:18 amRNSDirector/PDMR Shareholding
7th Dec 20237:00 amRNSDirector/PDMR Shareholding
29th Nov 20232:41 pmRNSDirector/PDMR Shareholding
21st Nov 20233:07 pmRNSDirector/PDMR Shareholding
20th Nov 20233:10 pmRNSDirector/PDMR Shareholding
17th Nov 20237:00 amRNSBoard Changes
17th Nov 20237:00 amRNSInterim Results
3rd Nov 20237:05 amRNSPresentation via Investor Meet Company
30th Oct 20231:40 pmRNSDirector/PDMR Shareholding
20th Oct 20237:00 amRNSSecond Quarter Trading Update
29th Sep 202310:56 amRNSDirector/PDMR Shareholding
21st Sep 20234:14 pmRNSDirector/PDMR Shareholding
18th Sep 20232:41 pmRNSDirector/PDMR Shareholding
30th Aug 202312:12 pmRNSDirector/PDMR Shareholding
25th Aug 202311:08 amRNSDirector/PDMR Shareholding
25th Aug 202310:38 amRNSDirector/PDMR Shareholding
23rd Aug 20232:31 pmRNSHolding(s) in Company
31st Jul 202311:05 amRNSDirector/PDMR Shareholding
27th Jul 20234:55 pmRNSResult of AGM
18th Jul 20237:00 amRNSFirst Quarter Trading Update
4th Jul 20231:55 pmRNSDirector/PDMR Shareholding
4th Jul 202312:05 pmRNSDirector/PDMR Shareholding
3rd Jul 20234:35 pmRNSNotice of AGM
30th Jun 20237:00 amRNSFinal Results
29th Jun 20237:00 amRNSPresentation via Investor Meet Company
28th Jun 20231:17 pmRNSDirector/PDMR Shareholding
2nd Jun 202311:48 amRNSDirector/PDMR Shareholding
28th Apr 20234:42 pmRNSDirector/PDMR Shareholding
28th Apr 20237:00 amRNSFourth Quarter Trading Update
27th Apr 20237:00 amRNSRecord invests in ADB's Kazakhstan Gender Bonds
31st Mar 20232:18 pmRNSDirector/PDMR Shareholding
28th Mar 20235:21 pmRNSDirector/PDMR Shareholding
16th Mar 20233:44 pmRNSHolding(s) in Company
16th Mar 20233:37 pmRNSDirector/PDMR Shareholding
9th Mar 20232:28 pmRNSDirector/PDMR Shareholding
8th Mar 202310:27 amRNSDirector/PDMR Shareholding
1st Mar 20237:00 amRNSDirectorate Change
28th Feb 20234:23 pmRNSDirector/PDMR Shareholding
9th Feb 20237:00 amRNSCapital Markets Teach-In

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.